Skip to main content
. 2015 Sep 28;2015:1101.
Ref (type) Population Outcome, Interventions Results and statistical analysis Effect size Favours
Physical functioning

RCT
60 adults with CFS (CDC criteria) attending a secondary-care centre
In review
Predefined increase in functional score (assessed by SF-36 questionnaire) 13 weeks
19/30 (63%) with CBT
5/30 (17%) with relaxation

RR 3.70
95% CI 2.37 to 6.31
NNT 3
95% CI 1 to 7
Moderate effect size CBT

RCT
3-armed trial
153 adults with CFS (CDC criteria)
In review
Change in functional score (assessed by SF-36 questionnaire)
with group CBT
with usual care
Absolute results not reported

Absolute difference –1.63 for group CBT v usual care
95% CI –4.05 to +0.78
Not significant

RCT
3-armed trial
153 people with CFS (CDC criteria)
In review
Change in functional score (assessed by SF-36 questionnaire)
with group CBT
with education and support
Absolute results not reported

Absolute difference –1.23 for group CBT v education and support
95% CI –3.52 to +1.05
Not significant

RCT
4-armed trial
90 adults with a mean age of 39.6 years who fulfilled diagnostic criteria for CFS (not further defined)
In review
Mean number of non-sedentary hours 7 months (3 months after completion of treatment)
5.2 with CBT plus placebo
5.2 with usual care plus placebo

Significance not assessed

RCT
4-armed trial
90 adults with a mean age of 39.6 years who fulfilled diagnostic criteria for CFS (not further defined)
In review
Mean score for ability to participate in daily activities (Karnofsky performance score) 7 months (3 months after completion of treatment)
72.1 with CBT plus placebo
73.4 with usual care plus placebo

Significance not assessed

RCT
4-armed trial
114 adults with CFS (defined by CDC criteria); baseline physical functioning scores 46.36 in people receiving CBT, 53.77 in people receiving relaxation
In review
Mean score on SF-36 for physical functioning 12 months
58.64 with CBT
61.20 with relaxation therapy

Significance not assessed

RCT
69 children and adolescents aged 10 to 17 years with CFS (CDC criteria) Change in functional score (assessed by short-form [SF]-36 questionnaire) 5 months
27.3 with CBT
10.0 with no treatment

Absolute difference 17.3
95% CI 6.2 to 28.4
Effect size not calculated CBT

RCT
63 adolescents aged 11–18 years with CFS (CDC or Oxford criteria)
In review
Mean score on SF-36 for physical functioning 6 months post treatment
80.4 with family-focused CBT
64.0 with psycho-education

Adjusted mean difference +13.42
95% CI –2.14 to +29.00
P = 0.09
Mean difference adjusted for associated baseline values
Not significant

RCT
131 adolescents aged 12–18 years with CFS (CDC criteria)
In review
Physical functioning (assessed by CHQ-CF87) 6 months
88.5 with internet CBT
70.1 with usual care

Mean difference 18.4
95% CI 12.9 to 23.9
P <0.0001
Effect size not calculated CBT

RCT
4-armed trial
641 adults with CFS (Oxford criteria) Mean score on SF-36 for physical functioning 52 weeks
58.2 with CBT
50.8 with specialist medical care

Mean difference 7.1
95% CI 2.0 to 12.1
P = 0.0068
Effect size not calculated CBT